EMJ Dermatology 9 [Supplement 2] . 2021

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and… Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

Gain valuable insights from three atopic dermatitis (AD) specialists who specifically consider one of the newest systemic therapies that targets the cytokine IL-13, a key cytokine involved in the pathogenesis of AD. Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.